Trigger Induced Migraine

1

Review clinical trials related to Trigger Induced Migraine. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US

Single-center, open label, prospective study conducted at Medstar Georgetown Headache Center. Men and woman ≥ 18 years old that are diagnosed with migraine with or without aura for at least 1 year, who report a reliable migraine trigger. Acceptable triggers for the study will include exercise, alcohol (less than one drink per day for woman and less than two drinks per day for men), air travel that lasts no more than 12 hours, sexual activity, fasting that lasts no more than 24 hours, stress or stress let-down headache.

Participants needed: 60
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Medstar Health Research InstituteUpdated: Dec 24, 2025Locations: 1
Eligibility criteria

Patients with at least 1 year history of episodic migraine (with or without aura... [+9]

Using gepants as preventive treatment (atogepant once daily (QD) or rimegepant e... [+4]